Williams & Connolly partner David Krinsky has been named a 2025 Law360 “MVP” in the Life Sciences category. According to the publication, “the attorneys chosen as Law360's 2025 MVPs have distinguished themselves from their peers by securing significant achievements in high-stakes litigation, complex global matters and record-breaking deals.”
In the last year, David has been involved in several high-profile patent litigation victories, including obtaining summary judgment on behalf of Pfizer in patent infringement litigation related to Pfizer’s blockbuster COVID-19 treatment Paxlovid; successfully challenging patents on behalf of Pfizer regarding their COVID-19 vaccine COMIRNATY; and earning an appellate victory on behalf of Merck in ANDA litigation concerning Bridion, a medication for the reversal of neuromuscular blockade.*
Click here to see the full list of Law360 MVPs.
* All cases vary and none are predictive.